Update: Creutzfeldt-jakob disease associated with cadaveric dura mater grafts - Japan, 1979-2003

Morbidity and Mortality Weekly Report

Volumn 52, Issue 48, 2003, Pages 1179-1181

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; LYODURA;

ADOLESCENT; ADULT; AGED; ARTICLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DURA MATER; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; ONSET AGE; TIME; TISSUE TRANSPLANTATION; TRANSPLANTATION; VIROLOGY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; COLLAGEN; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; TIME FACTORS; TISSUE TRANSPLANTATION;

EID: 0642373839     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. CDC. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts-Japan, January 1979-May 1996. MMWR 1997;46:1066-9.
2. Brown P, Preece M, Brandel JP, et al. latrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
3. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988;69:766-9.
4. CDC. Epidemiologie notes and reports update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR 1987;36:324-5.
5. U.S. Food and Drug Administration. Class II Special Controls Guidance Document: Human Dura Mater; Draft Guidance for Industry and PDA. Rockville, Maryland: U.S. Food and Drug Administration, 2002.
6. Solomon R. Methods used in human cells, tissues, and cellular and tissue-based product (HCT/P) establishments. Available at http://www.fda.gov/ ohrms/dockets/ac/03/transcripts/3969t2.pdf.